XBI (US) share price forecast & AI signal — State Street SPDR S&P Biotech ETF

Week of 2026-10-30 · ETF

What the model sees in XBI

State Street SPDR S&P Biotech ETF is a ETF stock listed on the US. For the week of 2026-10-30 the ACE machine-learning model rates it a HOLD with moderate confidence, based on technical indicators and the stock's own historical patterns across three time horizons. The direction is updated every model run.

About State Street SPDR S&P Biotech ETF

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

Recent closes

XBI FAQ

Is State Street SPDR S&P Biotech ETF (XBI) a buy or sell this week?

The ACE Stock Bots machine-learning model rates XBI a HOLD for the week of 2026-10-30 with moderate confidence. The exact confidence and the 1-week, 1-month and 3-month breakdown are free with a signup (5 analysis tokens, no card).

What is the AI share price forecast for XBI?

Every week the model scores XBI across three horizons using technical indicators and the stock's own historical patterns. An AI then writes a plain-English summary with support and resistance levels, and a bull analyst and a bear analyst argue the case.

Is this financial advice?

No. ACE Stock Bots provides general information generated by software. It does not consider your objectives, financial situation or needs. Read the disclaimer and consider licensed advice before acting.

Other ETF stocks on the US

AAAUACWIACWXAGGAIPOAIRRALLWAMLP

This week's top US picks · All US stocks

Signals are generated by software for general information only and are not a recommendation to buy or sell. See the disclaimer.